Published in AIDS Res Hum Retroviruses on May 20, 1998
High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol (2003) 2.04
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
Unequal evolutionary rates in the human immunodeficiency virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down when the epidemic rate increases. J Virol (2007) 1.47
Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol (1999) 1.22
Position and degree of mismatches and the mobility of DNA heteroduplexes. Nucleic Acids Res (2000) 1.14
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. AIDS Res Hum Retroviruses (2009) 0.99
Multiple HIV-1 introductions into the Swedish intravenous drug user population. Infect Genet Evol (2008) 0.89
A decline in the prevalence of injecting drug users in Estonia, 2005-2009. Int J Drug Policy (2013) 0.80
HIV-1 genetic variants in the Russian Far East. AIDS Res Hum Retroviruses (2014) 0.80
Short communication: molecular epidemiology of HIV type 1 infection in Kazakhstan: CRF02_AG prevalence is increasing in the southeastern provinces. AIDS Res Hum Retroviruses (2014) 0.79
In silico comparison of Iranian HIV -1 envelop glycoprotein with five nearby countries. Mol Biol Res Commun (2016) 0.75
Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities. Eur J Public Health (2015) 0.75
The global spread of HIV-1 subtype B epidemic. Infect Genet Evol (2016) 0.75
Inferring viral population structures using heteroduplex mobility and DNA sequence analyses. J Virol Methods (2013) 0.75
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1989) 4.79
The initiation sites for RNA transcription in Ad2 DNA. Cell (1977) 4.76
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol (1996) 4.43
The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping by effects of ultraviolet irradiation. Cell (1977) 4.13
Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies? Lancet (1992) 4.05
Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol (1990) 3.67
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A (2000) 3.44
The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping of nascent RNA molecules labeled in isolated nuclei. Cell (1977) 3.32
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol (1976) 2.88
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Lancet (1985) 2.72
Enhanced cellulase production by a mutant of Trichoderma viride. Appl Microbiol (1971) 2.67
HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction (1999) 2.67
AIDS and haemophilia: morbidity and morality in a well defined population. Br Med J (Clin Res Ed) (1985) 2.54
The role of the adenovirus protease on virus entry into cells. EMBO J (1996) 2.44
Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol (1994) 2.43
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science (1983) 2.26
Risky business: health and safety in the sex industry over a 9 year period. Sex Transm Infect (1999) 2.22
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
Prevalence of HIV infection in patients attending an inner city accident and emergency department. BMJ (1994) 2.15
P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem (1995) 2.12
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int J Cancer (1983) 2.08
Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet (1993) 2.03
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Sexual partner networks in the transmission of sexually transmitted diseases. An analysis of gonorrhea cases in Sheffield, UK. Sex Transm Dis (1997) 1.82
Mesenteric lymphadenitis and terminal ileitis due to yersinia pseudotuberculosis. N Engl J Med (1970) 1.82
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses (1988) 1.74
A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex Transm Infect (2000) 1.74
Premature termination during adenovirus transcription. Nature (1979) 1.70
Successful outcome of pregnancy in a phenylketonuric woman after low-phenylalanine diet introduced before conception. Lancet (1979) 1.69
HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. BMJ (1995) 1.69
Children in food-insufficient, low-income families: prevalence, health, and nutrition status. Arch Pediatr Adolesc Med (2001) 1.67
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol (1985) 1.64
Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry (2005) 1.63
A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab Invest (1990) 1.61
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol (1999) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA (1986) 1.59
Pacemaker localization and electrical conduction patterns in the canine stomach. Gastroenterology (1970) 1.59
Genetic identification of an endoproteinase encoded by the adenovirus genome. J Mol Biol (1983) 1.58
Respiratory efficacy of subglottic low-frequency, subglottic combined-frequency, and supraglottic combined-frequency jet ventilation during microlaryngeal surgery. Anesth Analg (2000) 1.56
Declining prevalence of STI in the London sex industry, 1985 to 2002. Sex Transm Infect (2004) 1.50
Biochemistry of the Na+, D-glucose cotransporter of the small-intestinal brush-border membrane. The state of the art in 1984. Biochim Biophys Acta (1984) 1.48
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ (1991) 1.48
Limits of two-dimensional planimetry in the follow-up of glaucomatous optic discs. Graefes Arch Clin Exp Ophthalmol (1995) 1.48
Group C adenovirus DNA sequences in human lymphoid cells. J Virol (1986) 1.47
Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry (2009) 1.47
Internal anal sphincter repair. Int J Colorectal Dis (1997) 1.47
The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol (1994) 1.46
Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study. J Infect Dis (1995) 1.43
Prophylaxis and management of hamstring muscle injuries in intercollegiate football players. Am J Sports Med (1984) 1.42
The development of a surveillance system to monitor emergency food relief in New York State. Am J Public Health (1987) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Contribution of maternal viral load to HIV-1 transmission. Lancet (1992) 1.41
In vitro cleavage specificity of the adenovirus type 2 proteinase. Biochim Biophys Acta (1983) 1.40
Cerebral mass lesions in patients with AIDS. BMJ (1990) 1.40
What is the meaning of colorectal transit time measurement? Dis Colon Rectum (1992) 1.39
Development of HIV-1 group-specific neutralizing antibodies after seroconversion. AIDS (1992) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
[Stapler hemorrhoidectomy. A new alternative to conventional methods]. Zentralbl Chir (1999) 1.39
Antiglucocorticoid effects of DHEA-S in Alzheimer's disease. Am J Psychiatry (1992) 1.38
Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature (1992) 1.37
Protease of adenovirus type 2: partial characterization. Virology (1979) 1.36
Production of viral mRNA in adenovirus- transformed cells by the post- transcriptional processing of heterogeneous nuclear RNA containing viral and cell sequences. J Virol (1973) 1.35
An unusual case of Hughes-Stovin syndrome. Eur Respir J (1998) 1.33
Structure of adenovirus chromatin. Biochim Biophys Acta (1982) 1.33
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res (2000) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Importance of F1-ATPase residue alpha-Arg-376 for catalytic transition state stabilization. Biochemistry (1999) 1.30
Genetic analysis of adenovirus type 2. I. Isolation and genetic characterization of temperature-sensitive mutants. J Virol (1975) 1.30
Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem (1992) 1.28
North Carolina macular dystrophy (MCDR1). A review and refined mapping to 6q14-q16.2. Ophthalmic Paediatr Genet (1993) 1.28
Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet (1996) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Lancet (1984) 1.26
Global and regional reproducibility of T2 relaxation time measurements in human patellar cartilage. Magn Reson Med (2006) 1.25
HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet (1985) 1.25
High-resolution diffusion tensor imaging of human patellar cartilage: feasibility and preliminary findings. Magn Reson Med (2005) 1.25
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? Immunol Lett (2001) 1.24
Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res (1983) 1.24
Quantitation of the interaction between adenovirus types 2 and 5 and microtubules inside infected cells. Virology (1980) 1.24
Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.21
Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology (1986) 1.21
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. J Hepatol (1998) 1.20
Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma. Clin Cancer Res (1999) 1.20
Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet (1984) 1.19
Use of sedation for routine diagnostic upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society Members. Digestion (2006) 1.19
In vitro RNA-RNA splicing in adenovirus 2 mRNA formation. Proc Natl Acad Sci U S A (1978) 1.19
Is AIDS an epidemic form of African Kaposi's sarcoma? Discussion paper. J R Soc Med (1984) 1.18
Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS (1994) 1.18